Skip to main content

Why was London hit first by Omicron?

One question I have been asked is why the London-region has been the area of the UK most affected by the Omicron variant of SARS-CoV-2? Over 80% of Covid-19 cases in London are thought to be due to Omicron compared to a national average in England (as of 19 November) of 67%. 

There are several factors that have driven the rapid increase in Omicron cases in London.

London is the UK’s main international travel hub with the UK’s busiest airports located nearby. Hence, travellers from overseas who are infected with a new variant of SARS-CoV-2 are more likely to arrive in the London region than in other parts of the UK. London also has a very large number of international visitors – for activities such as work, study, tourism, leisure, and sports events. 

London is the also UK’s largest city and is very densely populated, with many overcrowded households, often with people from three generations living together (multi-generation households), which makes infections more likely to spread.

London has a lower vaccination uptake than other parts of the UK. Around 20% of adults in London currently remain unvaccinated. Although vaccines provide less protection from infection with Omicron than from the Delta variant, they do still provide some protection; more so in people who have had their first two primary vaccinations followed by a booster vaccination. The lower vaccination rate will lead to infections from Omicron spreading more quickly; as well as increasing the likelihood of severe disease. This would in turn increase hospital admissions and pressures across the NHS in London.

We will see Omicron spread across the rest of the UK in the next few weeks. However, it may be the case that the higher levels of vaccination elsewhere in the UK will blunt the symptoms from an Omicron infection; with fewer people developing a more serious illness than in London. This remains to be determined and new data in the next few weeks should answer this question.

Comments

Post a Comment

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...
Post a Comment
Read more

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...
Post a Comment
Read more

What makes a good doctor – and who gets to decide?

What Makes a Good Doctor? This is the question that Waseem Jerjes and I explore in the Journal of the Royal Society of Medicine . It is a key question that underpins the architecture of medical education, clinical practice, regulation, and professional identity. It cannot be answered by regulators, educators, or employers in isolation. It must be answered together – by doctors and patients – revisited throughout a career, and adapted as society and the profession change. Without that shared reflection, the danger is not simply disillusionment, but the erosion of the moral foundations of clinical work. As we enter an era when diagnosis will increasingly involve artificial intelligence and when performance metrics reward volume over value, reclaiming this question as a professional one is imperative. The integrity of our institutions – and of the practitioners within them – depends on reimagining excellence in inclusive, relational terms. A good doctor is not a flawless technician or a f...
Post a Comment
Read more